Heartwood Wealth Advisors’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$341K Sell
1,750
-573
-25% -$119K 0.03% 175
2026
Q1
$521K Hold
2,323
0.05% 129
2025
Q4
$560K Hold
2,323
0.05% 112
2025
Q3
$636K Hold
2,323
0.06% 103
2025
Q2
$599K Sell
2,323
-27
-1% -$6.44K 0.06% 104
2025
Q1
$526K Sell
2,350
-50
-2% -$11.7K 0.06% 98
2024
Q4
$549K Hold
2,400
0.06% 93
2024
Q3
$586K Sell
2,400
-125
-5% -$27.9K 0.06% 92
2024
Q2
$483K Buy
+2,525
New +$512K 0.06% 99
2023
Q3
Sell
-1,000
Closed -$219K 142
2023
Q2
$219K Hold
1,000
0.03% 126
2023
Q1
$219K Hold
1,000
0.03% 121
2022
Q4
$208K Hold
1,000
0.03% 120
2022
Q3
$218K Hold
1,000
0.04% 107
2022
Q2
$210K Hold
1,000
0.03% 111
2022
Q1
$243K Buy
+1,000
New +$242K 0.04% 104

Other funds holding RMD

Heartwood Wealth Advisors's RMD Position: Q2 2026 in Review

Heartwood Wealth Advisors reduced its ResMed (RMD) stake by 25% in Q2 2026, selling an estimated $119K and leaving 1,750 shares worth $341K. The position accounts for 0.03% of the portfolio, ranked #175.

Heartwood Wealth Advisors first reported a position in RMD in Q1 2022 and has held it in 15 quarters since. The position peaked at $636K in Q3 2025. 103 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Heartwood Wealth Advisors held 1,750 shares of ResMed worth $341K as of Q2 2026.
  • Heartwood Wealth Advisors sold 573 ResMed shares in Q2 2026, an estimated $119K.
  • ResMed made up 0.03% of Heartwood Wealth Advisors's portfolio in Q2 2026, its #175 holding.
  • Heartwood Wealth Advisors first reported a position in ResMed in Q1 2022 and has held it in 15 quarters since.
  • Heartwood Wealth Advisors's ResMed position peaked at $636K in Q3 2025.
  • 103 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Heartwood Wealth Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.